Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis (Q35233352)
Jump to navigation
Jump to search
scientific article published on August 17, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis |
scientific article published on August 17, 2011 |
Statements
1 reference
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis (English)
1 reference
Jennifer A. Dickens
David A. Lomas
17 August 2011
7 references
24 March 2019
22 April 2019
20 November 2019
27 November 2019
13 December 2019
31 January 2021
7 references
24 March 2019
22 April 2019
20 November 2019
27 November 2019
13 December 2019
31 January 2021
5
1 reference
391-405
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference